NP
		Neuropathology and Pathogenesis
	 
					
	
	Thursday, May 25, 2017: 6:15 PM-8:15 PM
	B2 (New Orleans Convention Center)
	
	
	
	
	
	
	
	
		
	
		
			
		
		
	
	
	
		
	
		
			
				Comparison of Etomoxir, a Lipid Metabolism Blocker, and Interferon-Beta Treatment on Antibody Recognition of Brain Proteins in Multiple Sclerosis
			
			
				
					
						Anne S Moerkholt, MSc, Aalborg University; 
					
						Kenneth Kastaniegaard, MSc, Aalborg University; 
					
						Michael Trabjerg, MD, Aalborg University; 
					
						Gopana Gopalasingam, BSc, Aalborg University; 
					
						Wanda Niganze, BSc, Aalborg University; 
					
						Michal K Oklinski, Postdoc, Aalborg University; 
					
						Agnete Larsen, PhD, Associate Prof., Aarhus University; 
					
						Jette GK Nieland, MSc, Meta-IQ ApS; 
					
						Allan Stensballe, PhD, Associate Prof., Aalborg University; 
					
						Soren Nielsen, MD, Prof., Aalborg University; 
					
						John D Nieland, PhD, Associate Prof., Aalborg University; 
					
						Anne S Moerkholt, MSc, Aalborg University
					
				
			
			
			
		
	 
 
	
		
			
		
		
	
	
	
		
	
		
			
				Characterization of Humane Autoantibody Response to Brain Proteins in Multiple Sclerosis Patients
			
			
				
					
						Anne S Moerkholt, MSc, Aalborg University; 
					
						Kenneth Kastaniegaard, MSc, Aalborg University; 
					
						Allan Stensballe, PhD, Associate Prof., Aalborg University; 
					
						Soren Nielsen, MD, Prof., Aalborg University; 
					
						John D Nieland, PhD, Associate Prof., Aalborg University; 
					
						Anne S Moerkholt, MSc, Aalborg University
					
				
			
			
			
		
	 
 
	
		
			
		
		
	
	
	
		
	
		
			
				Effect of Teriflunomide on Lymphocyte Counts and Infections over the Long-Term in the TEMSO Extension Study
			
			
				
					
						Giancarlo Comi, MD, University Vita-Salute San Raffaele; 
					
						Aaron E Miller, MD, Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai; 
					
						Myriam Benamor, MD, Sanofi; 
					
						Philippe Truffinet, MD, Sanofi; 
					
						Karthinathan Thangavelu, PhD, Sanofi Genzyme; 
					
						Mark S Freedman, MD, University of Ottawa and the Ottawa Hospital Research Institute; 
					
						Heather St Michael, BSc, Fishawack
					
				
			
			
			
		
	 
 
	
		
			
		
		
	
	
	
		
	
		
			
				Modifications like Citrulination and MDA Adducts, Lipidation and the Immune System; A Menage a Trois Gone Wrong in Multiple Sclerosis
			
			
				
					
						Kenneth Kastaniegaard, MSc, Aalborg University; 
					
						John D Nieland, PhD, Associate Prof., Aalborg University; 
					
						Anne S. Mørkholt, PhD Student, Aalborg University; 
					
						Allan Stensballe, PhD, Associate Prof., Aalborg University; 
					
						Soeren Nielsen, MD. Prof., Aalborg University; 
					
						Kenneth Kastaniegaard, MSc, Aalborg University
					
				
			
			
			
		
	 
 
	
		
			
		
		
	
	
	
		
	
		
			
				Expanding the Concept of Paraneoplastic Neuromyelitis Optica: A Cohort Description with Histological Staining
			
			
				
					
						Philippe Beauchemin, MD, UBC MS Clinic; 
					
						C. Blake Gilks, MD, University of British Columbia; 
					
						Raffaele Iorio, MD, PHD, Istituto di Neurologia  Universitŕ Cattolica del Sacro Cuore; 
					
						Anthony Traboulsee, MD, University of British Columbia; 
					
						Thalia Field, MD, MHSc, University of British Columbia; 
					
						Robert Carruthers, MD, University of British Columbia; 
					
						Philippe Beauchemin, MD, UBC MS Clinic